Scribe → News
Scribe Therapeutics
About
Platform
Pipeline
News
Careers
Contact
LinkedIn
Twitter or X
Menu
Close
News + Resources
Keep up with the latest
Featured
This Scientist Is Building Custom Gene-Editing Tools
This Scientist Is Building Custom Gene-Editing Tools
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
CRISPR 2.0, the Next Generation
June 21, 2024
Aspen Ideas: Health
CRISPR 2.0, the Next Generation
June 21, 2024
The Age of CRISPR: Engineering the Future of Genetic Medicine
February 23, 2024
TEDxBerkeley
The Age of CRISPR: Engineering the Future of Genetic Medicine
February 23, 2024
All Stories
All
News
Press Releases
Previous
Load More
News
Scribe Therapeutics emerges with $20M, Biogen pact to clear CRISPR hurdles
October 7, 2020
Fierce Biotech
Read Now
News
Starting with Biogen deal in ALS, Scribe planning a new chapter in CRISPR story
October 7, 2020
BioWorld
Read Now
News
Biogen, gene-editing startup Scribe to develop therapies for Lou Gehrig's disease
October 6, 2020
Reuters
Read Now
News
Scribe Therapeutics launches to explore next-generation CRISPR technology
October 6, 2020
Chemical & Engineering News
Read Now
News
CRISPR startup Scribe Therapeutics lands big Biogen deal
October 6, 2020
San Francisco Business Times
Read Now
News
Scribe: engineering CRISPR’s next generation
October 6, 2020
BioCentury
Read Now
Previous
Load More
Press release
Scribe Therapeutics to Highlight In Vivo CRISPR-based Genome Editing Data for Duchenne Muscular Dystrophy at ASGCT 2025, in Addition to Joint Presentation with Prevail Therapeutics, a part of Lilly’s Gene Therapy Division
May 5, 2025
Read Now
Press release
Scribe Achieves Milestone for In Vivo Program in Collaboration with Prevail Therapeutics, a part of Lilly’s Gene Therapy Division, and Announces ASGCT Joint Presentation on Self-Inactivating AAV Technology for Neurological and Neuromuscular Disorders
April 28, 2025
Read Now
Press release
Scribe Therapeutics to Unveil Latest Preclinical Data on Proprietary CRISPR Epigenetic Silencing Technology for LDL-C Lowering at the 2025 EAS Congress
April 23, 2025
Read Now
Press release
Scribe Therapeutics Presents Data on its Epigenetic Long-Term X-Repressor Technology at the 2025 Keystone Symposia on Precision Genome Engineering Conference
March 7, 2025
Read Now
Press release
Scribe Therapeutics to Participate in Upcoming Conferences
February 26, 2025
Read Now
Press release
Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi
January 13, 2025
Read Now
Previous
Load More
Publications and presentations
Presentation
Scribe Corporate Deck 2025 Q1
February 3, 2025
Read Now
Publication
CasX enzymes comprise a distinct family of RNA-guided genome editors
February 4, 2019
Nature
Read Now
Publication
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
May 1, 2017
Nature Biotechnology
Read Now
Publication
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
March 2, 2017
Nucleic Acids Research
Read Now
Publication
Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
June 1, 2016
Nature Biotechnology
Read Now
Publication
Multi-reporter selection for the design of active and more specific zinc-finger nucleases for genome editing
January 7, 2016
Nature Communications
Read Now
Publication
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
December 15, 2014
eLife
Read Now
Publication
Programmable RNA recognition and cleavage by CRISPR/Cas9
December 11, 2014
Nature
Read Now
Publication
MicroRNA-mediated switching of chromatin-remodelling complexes in neural development
July 30, 2009
Nature
Read Now